Technique for detecting HIV-1 proviral DNA by PCR: The case of newborns

 

Journal of Applied Biosciences 220: 24338 – 24340

ISSN 1997-5902

 

Technique for detecting HIV-1 proviral DNA by PCR: The case of newborns

 

Laure Stella Ghoma Linguissi1,2,3, Tani Sagna2,3,4, Jacques Simpore2,3

1Institut national de Recherche en Sciences de la Santé (IRSSA), Brazzaville, République du Congo

2Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA)/LABIOGENE, UFR/SVT, Université de Ouagadougou, Burkina Faso

3Centre Médical Saint Camille, Ouagadougou, Burkina Faso

4Institut de Recherche en Sciences de la Santé (IRSS), Ouagadougou, Burkina-Faso

Email: linguissi@gmail.com

 

Submitted 10/02/2026, Published online on 31/05/2026 in the  https://www.m.elewa.org/journals/journal-of-applied-biosciences-about-jab/     https://doi.org/10.35759/JABs.220.1

 

INTRODUCTION

 

Polymerase chain reaction (PCR)testing for integrated viral DNA (proviral DNA) is the standard method used for early detection of HIV in newborns. In developing countries, this approach has been made more accessible through the dried blood spot (DBS) technique. The medical challenge is to identify infants infected via vertical transmission of HIV so that they can receive antiretroviral (ARV) treatment early. In resource-limited countries, there are many advantages to using DBS samples rather than whole blood for PCR testing to detect DNA.

 

 

MATERIALS AND METHODS

 

Extraction of proviral DNA using DBS: Cutting: Prepare AW1 and AW2 buffers according to the manufacturer’s instructions; Cut 3 mm diameter pellets from a drop of dried blood using scissors; Transfer the pellet pieces from the blotting paper containing the dried blood into a 1.5 ml tube and add 180 μl of ATL buffer;

Lysis: Pipette 180 μl of ATL buffer into the tubes containing 100 μl of plasma RNA pellet; Incubate for 10 min at 85°C. Add 20 μl of Proteinase K solution, mix by vortexing, then incubate for 1 hour at 56°C. Centrifuge briefly to recover the droplets accumulated in the cap. Add 200 μl of AL buffer to the sample, mix vigorously by vortexing, then incubate for 10 min at 70°C. Centrifuge briefly;

Fixation: Add 200 μl of absolute ethanol to the sample and mix vigorously by vortexing. Centrifuge briefly; Carefully place the mixture obtained in step 6 into the QIAmp column without wetting the edge. Close the cap and centrifuge for 1 min at 8000 rpm.  Transfer the QIAmp column to a 2 ml collection tube and discard the tube containing the effluent.

Washing: Add 500 μl of AW1 buffer. Centrifuge for 1 minute at 8000 rpm; transfer the QIAmp column to a 2 ml collection tube and discard the tube containing the effluent; add 500 μl of AW2 buffer. Close the cap and centrifuge for 3 minutes at 14,000 rpm. Place the QIAMP column in a new 2 ml collection tube and discard the old collection tube containing the effluent. Centrifuge for 1 min at 14,000 rpm; Transfer the QIAmp column to a clean 1.5 ml tube. Discard the old collection tube containing the effluent;

Elution: Add 70μl of elution buffer. Incubate for 1 min at room temperature, then centrifuge for 1 min at 8,000 rpm.

Preparation of qualitative PCR: Polymerase chain reaction (PCR) was initially conducted using the DNA samples. The Generic DNA Cell Kit (Biocentric, Bandol, France) was employed for this procedure. A second PCR of the DBS spot DNA was performed to confirm the real-time PCR results for samples with an indeterminate (doubtful) serological status, which proved negative in the qualitative real-time PCR. The amplification reaction mixture is described in Table 1 below:

 

 

Table 1: PCR Reaction Mixture

MIX components Volume μl
qPCR mix with platinum Taq 60U/ml + Rox 25
Primer A 1
Primer B 1
Probe C 1
Sterile water 2
Total 30 μl

 

 

PCR was performed in a 9700 thermal cycler (Applied Biosystems, USA) in a reaction volume of 50 μl comprising 30 μl of mix and 20 μl of DNA according to the amplification program described in Table 2.

 

 

Table 2: PCR amplification program

Stages Time Temperature
Initial Denaturation 2 min 50°C
Enzyme activation 50 cycles

 

10 min 95°C
Denaturation 50 cycles 15 s 95°C
Hybridization 1 min 60°C

 

 

Figure 1: PCR product on agarose gel, under UV light                  Figure 2: Preparation of DNA extraction

Legend: MW = Molecular weight marker (Fermentas: GeneRuler™ DNA Ladders “GeneRuler™ DNA Ladder Mix,” ready-to-use, ≠ SM 0333; 100-10,000 bp).

Well 24 = positive control; Well 25 = negative control

In wells 1, 2, 4, 5, 7, 8, 9, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, we have visible band s: these samples are PCR positive. Wells 3, 6, 12, 21, 22, and 23 correspond to PCR-negative samples. The expected DNA bands formed between 100 and 200 base pairs (bp), which corresponds to the expected fragment size of approximately 110 to 120 bp.

Advantages and limitations of the technique

Advantages Limitations
Less expensive technique

Rapid detection of proviral DNA

Limited use of sophisticated equipment

Requires venous blood sampling from the newborn.

Viral load cannot be estimated using this technique, as a positive result only indicates the presence of the virus

 

 

Conclusion: Early diagnosis of HIV plus early treatment are the cornerstones of successful paediatric HIV/AIDS care as they reduce morbidity and mortality. This means that more newborns are diagnosed early and t remain healthier. Promoting PCR as a routine technique for the early diagnosis of HIV infection in newborns is now widely recognized as best practice.

 

 

 

Contact: Dr. GHOMA LINGUISSI Laure Stella, Institut National de Recherche en Sciences de la Santé. Cité Scientifique, Ex ORSTOM, Route de l’Auberge de Gascogne, quartier Ngangouoni-Château d’eau, Brazzaville. Email: linguissi@gmail.com

 

 

Posted in .